Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
TSI-GSD-200 by Defender Pharmaceuticals for Rift Valley Fever: Likelihood of Approval
TSI-GSD-200 is under clinical development by Defender Pharmaceuticals and currently in Phase II for Rift Valley Fever. According to GlobalData,...